SCHEMBL22204644

SCHEMBL22204644

CC[Ge](CC)(CC)C(=O)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CES1 P23141 8/20 0.48
▸ CES2 O00748 7/20 0.48
▸ TSHR P16473 3/20 0.46
▸ CYP3A4 P08684 2/20 0.46
▸ MAPT P10636 2/20 0.46
▸ TDP1 Q9NUW8 2/20 0.46
▸ POLB P06746 1/20 0.46
▸ PARP1 P09874 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ RECQL P46063 1/20 0.46
▸ BLM P54132 1/20 0.46
▸ PMP22 Q01453 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ MAPK1 P28482 2/20 0.44
▸ HPGD P15428 2/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ ALOX15 P16050 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4953144 0.94 CES1 (0.44) CES1CES2TSHRCYP3A4MAPT
SCHEMBL4019209 0.82 CES1 (0.48) CES1CES2TSHRCYP3A4MAPT
SCHEMBL274249 0.82 CES1 (0.48) CES1CES2TSHRCYP3A4MAPT
Bromomethane SCHEMBL30082988 0.78 CES1 (0.45) CES1CES2TSHRCYP3A4MAPT
SCHEMBL4953798 0.77 CES2 (0.47) CES1CES2ALDH1A1LMNA
SCHEMBL1632835 0.75 TDP1 (0.55) CES1CES2TSHRCYP3A4MAPT
SCHEMBL272138 0.75 TDP1 (0.55) CES1CES2TSHRCYP3A4MAPT
SCHEMBL14795001 0.75 TSHR (0.45) CES1CES2TSHRCYP3A4MAPT
SCHEMBL4019838 0.74 CES1 (0.47) CES1CES2TSHRCYP3A4MAPT
SCHEMBL18687120 0.72 TDP1 (0.57) CES1CES2TSHRCYP3A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3911687-B1 LIMONENE-BASED (METH)ACRYLATES FOR USE IN 3D PRINTING BASF SE (DE) 2023-11-01 — — EP disclosed
US-20220064350-A1 LIMONENE-BASED (METH)ACRYLATES FOR USE IN 3D PRINTING BASF SE (DE) 2022-03-03 — — US disclosed
US-20220064349-A1 HYDROXYURETHANE (METH)ACRYLATE PREPOLYMERS FOR USE IN 3D PRINTING BASF SE (DE) 2022-03-03 — — US disclosed
EP-3911691-A1 HYDROXYURETHANE (METH)ACRYLATE PREPOLYMERS FOR USE IN 3D PRINTING BASF SE (DE) 2021-11-24 — — EP disclosed
EP-3911687-A1 LIMONENE-BASED (METH)ACRYLATES FOR USE IN 3D PRINTING BASF SE (DE) 2021-11-24 — — EP disclosed
CN-113302226-A Hydroxyl urethane (meth) acrylate prepolymers for use in 3D printing 巴斯夫欧洲公司 2021-08-24 — — CN disclosed
CN-113302216-A Limonene-based (meth) acrylates for 3D printing 巴斯夫欧洲公司 2021-08-24 — — CN disclosed
WO-2020148189-A1 LIMONENE-BASED (METH)ACRYLATES FOR USE IN 3D PRINTING BASF SE (DE) 2020-07-23 — — WO disclosed
WO-2020148190-A1 HYDROXYURETHANE (METH)ACRYLATE PREPOLYMERS FOR USE IN 3D PRINTING BASF SE (DE) 2020-07-23 — — WO disclosed
EP-3680263-A1 LIMONENE-BASED (METH)ACRYLATES FOR USE IN 3D PRINTING BASF SE (DE) 2020-07-15 — — EP disclosed
EP-3680274-A1 HYDROXYURETHANE (METH)ACRYLATE PREPOLYMERS FOR USE IN 3D PRINTING BASF SE (DE) 2020-07-15 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220064350-A1 LIMONENE-BASED (METH)ACRYLATES FOR USE IN 3D PRINTING LIMK1, LIMA1, LIMK2 CES1 3059/4885CES2 1792/4885TSHR 3518/4885
US-20220064349-A1 HYDROXYURETHANE (METH)ACRYLATE PREPOLYMERS FOR USE IN 3D PRINTING PAH, UGT1A3, HTR3D CES1 2977/4885CES2 555/4885TSHR 4576/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback